
Repligen Corporation RGEN
$ 165.31
0.88%
Quarterly report 2025-Q3
added 11-04-2025
Country |
|
IPO year |
1986 |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
55.7 K |
Market Cap[1] |
$ 9.21 M |
EBITDA (LTM) |
$ 77 M |
P/E (LTM) |
264.29 |
P/S (LTM) |
0.01 |
EPS (LTM) |
0.62 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Baxter International
BAX
|
$ 19.57 | 2.46 % | $ 9.98 B | NYSE,SPB | ||
|
Becton, Dickinson and Company
BDX
|
$ 195.21 | 0.6 % | $ 56.2 B | NYSE,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Ekso Bionics Holdings
EKSO
|
$ 7.92 | -8.39 % | $ 160 M | Nasdaq Capital Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Harvard Bioscience
HBIO
|
$ 0.66 | -1.57 % | $ 28 M | Nasdaq Global Market | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Repro Med Systems
KRMD
|
$ 5.68 | -2.24 % | $ 259 M | Nasdaq Capital Market | ||
|
Alcon
ALC
|
$ 77.25 | -1.98 % | $ 40.4 B | NYSE | ||
|
AtriCure
ATRC
|
$ 39.07 | -1.24 % | $ 1.83 B | Nasdaq Global Market,SPB | ||
|
ICU Medical
ICUI
|
$ 141.14 | -1.07 % | $ 3.44 B | Nasdaq Global Select Market,SPB | ||
|
electroCore
ECOR
|
$ 4.57 | 1.78 % | $ 25.2 K | Nasdaq Global Select Market | ||
|
Merit Medical Systems
MMSI
|
$ 86.79 | -1.54 % | $ 5.05 B | Nasdaq Global Select Market,SPB | ||
|
iRhythm Technologies
IRTC
|
$ 176.54 | -0.51 % | $ 5.51 B | Nasdaq Global Select Market,SPB | ||
|
AngioDynamics
ANGO
|
$ 12.65 | -1.48 % | $ 517 M | Nasdaq Global Select Market | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
The Cooper Companies
COO
|
$ 81.63 | -0.4 % | $ 16.3 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 4.85 | -0.72 % | $ 50.4 M | Nasdaq Global Select Market | ||
|
Glaukos Corporation
GKOS
|
$ 111.49 | -1.26 % | $ 5.4 B | NYSE,SPB | ||
|
LeMaitre Vascular
LMAT
|
$ 80.65 | -0.56 % | $ 1.81 B | Nasdaq Global Market,SPB | ||
|
Haemonetics Corporation
HAE
|
$ 79.49 | -0.82 % | $ 4 B | NYSE,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 8.73 | -2.68 % | $ 180 M | NYSE American | ||
|
Masimo Corporation
MASI
|
$ 127.37 | -2.07 % | $ 6.79 B | Nasdaq Global Select Market,SPB | ||
|
Intuitive Surgical
ISRG
|
$ 559.13 | -1.28 % | $ 199 B | Nasdaq Global Select Market,SPB | ||
|
OraSure Technologies
OSUR
|
$ 2.44 | 1.03 % | $ 182 M | Nasdaq Global Select Market,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.04 | 2.0 % | $ 20.8 M | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.28 | 1.65 % | $ 22.3 M | NYSE American | ||
|
Stereotaxis
STXS
|
$ 2.29 | -0.43 % | $ 185 M | NYSE American | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 21.77 | 0.25 % | $ 3.75 B | NYSE | ||
|
STERIS plc
STE
|
$ 248.73 | -1.89 % | $ 24.5 B | NYSE,SPB | ||
|
Pro-Dex
PDEX
|
$ 37.63 | -2.21 % | $ 124 M | Nasdaq Global Select Market | ||
|
Predictive Oncology
POAI
|
- | - | $ 32.4 M | Nasdaq Capital Market | ||
|
Pulse Biosciences
PLSE
|
$ 13.5 | -1.68 % | $ 649 M | Nasdaq Global Select Market | ||
|
Utah Medical Products
UTMD
|
$ 55.99 | 0.05 % | $ 203 M | Nasdaq Global Select Market | ||
|
ResMed
RMD
|
$ 244.33 | 1.46 % | $ 35.7 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.47 | 0.31 % | $ 2.33 B | Nasdaq Global Select Market,SPB | ||
|
BioLife Solutions
BLFS
|
$ 24.07 | -0.48 % | $ 1.11 B | Nasdaq Global Select Market | ||
|
Retractable Technologies
RVP
|
$ 0.77 | -0.27 % | $ 23.1 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 23.53 | 1.88 % | $ 1.16 B | Nasdaq Global Market,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 122.01 | -0.06 % | $ 5.71 B | NYSE,SPB | ||
|
West Pharmaceutical Services
WST
|
$ 274.04 | -0.4 % | $ 20 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.